{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.5253.5253",
    "article_title": "First-Line Treatment with Nilotinib in Chronic Myeloid Leukemia Patients in Real-Life: Results of the Observational Study Gimema CML0912 ",
    "article_date": "December 7, 2017",
    "session_type": "632. Chronic Myeloid Leukemia: Therapy",
    "abstract_text": "INTRODUCTION. Three tyrosine-kinase inhibitors (TKIs, imatinib, nilotinib [NIL] and dasatinib) are approved for first-line treatment of CP CML. Clinical trials, with stringent inclusion/exclusion criteria and management, may be not fully representative of the daily clinical practice. Thus, it is important to retrieve information on the safety and efficacy of TKIs in the real-life setting. Observational studies are particularly useful for these evaluations. AIM. To investigate the safety and efficacy of NIL as first line treatment of newly diagnosed CP CML pts in the real-life setting METHODS. Prospective, multicenter, observational study. Inclusion criteria: CP CML within 6 months from diagnosis; no prior treatment with TKIs; written informed consent. Comorbidities (of any kind and severity) were not exclusion criteria. NIL was used according to prescribing information (initial dose 300 mg BID). There was no formal indication for dose modifications, management of adverse events, and response monitoring. RESULTS. Between 06/2013 and 11/2015, 123 pts were enrolled in 27 Italian Centers; median age: 51 yrs; Sokal high-risk pts: 19%; EUTOS high-risk pts: 7%. Despite Median follow-up: 18 months (updated results will be presented). At the last contact, of evaluable pts with at least 12 months of follow-up, 78% and 43% of pts were in MR3 and MR4, respectively. At the last contact, all but one pt were alive. 113 (89%) pts were still on study (on NIL treatment); in the remaining pts, NIL discontinuation occurred in: 9 pts for failure/suboptimal response, including 1 progression to blast phase; 2 pts for toxicity; 1 pt for a CML-unrelated death, 2 pts for other reasons. CONCLUSION. These preliminary data in real-life CP CML pts treated with NIL first-line showed that: 1) despite the absence of exclusion criteria for comorbidities, the median age of enrolled pts (51 years) was similar to that reported in clinical trials, and inferior to the median age of CML pts in population based-registries; 2) NIL use was not limited to intermediate or high-risk pts; 3) efficacy was similar to that reported in clinical trials, with very low rates of progression to advanced phase and high molecular response rates. Disclosures Gugliotta: Novartis: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria; Incyte: Consultancy, Honoraria. Castagnetti: Incyte: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria; Bristol-Myers Squibb: Consultancy, Honoraria. Abruzzese: Novartis: Consultancy; Incyte: Consultancy; BMS: Consultancy; Pfizer: Consultancy. Breccia: Pfizer: Consultancy; Bristol Myers Squibb: Consultancy; Incyte: Consultancy; Novartis: Consultancy. Iurlo: Novartis: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria. Tiribelli: Novartis: Consultancy, Honoraria; Bristol Myers Squibb: Consultancy, Honoraria; Incyte: Consultancy, Honoraria. Crugnola: BMS: Honoraria; Celgene: Honoraria; Novartis: Honoraria. Bonifacio: Incyte: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees, Research Funding; Bristol-Myers Squibb: Membership on an entity's Board of Directors or advisory committees. Soverini: Incyte Biosciences: Consultancy; Novartis: Consultancy; Bristol-Myers Squibb: Consultancy. Fo\u00e0: Janssen: Consultancy, Speakers Bureau; Celgene: Consultancy, Speakers Bureau; Novartis: Consultancy, Speakers Bureau; Abbvie: Consultancy, Speakers Bureau; Gilead: Consultancy, Speakers Bureau; Amgen: Consultancy, Speakers Bureau; BMS: Consultancy, Speakers Bureau; Roche: Consultancy, Speakers Bureau; Sandoz: Consultancy, Speakers Bureau. Martinelli: PFIZER: Consultancy; JOHNSON & JOHNSON: Consultancy; CELGENE: Consultancy; ROCHE: Consultancy; ARIAD/INCYTE: Consultancy; AMGEN: Consultancy. Pane: Novartis: Honoraria, Speakers Bureau. Saglio: Pfizer: Consultancy, Honoraria; Ariad: Consultancy, Honoraria; Roche: Consultancy, Honoraria; BMS: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Incyte: Consultancy, Honoraria. Baccarani: Novartis: Consultancy, Honoraria, Speakers Bureau; Bristol-Myers Squibb: Honoraria, Speakers Bureau; Pfizer: Honoraria, Speakers Bureau; Incyte ARIAD: Consultancy, Honoraria, Speakers Bureau. Rosti: Pfizer: Research Funding, Speakers Bureau; Novartis: Research Funding, Speakers Bureau; Bristol Myers Squibb: Research Funding, Speakers Bureau; Incyte: Research Funding, Speakers Bureau.",
    "topics": [
        "leukemia, myelocytic, chronic",
        "nilotinib",
        "observational studies",
        "brachial plexus neuritis",
        "protein-tyrosine kinase inhibitor",
        "follow-up",
        "adverse event",
        "blast phase",
        "dasatinib",
        "imatinib mesylate"
    ],
    "author_names": [
        "Gabriele Gugliotta, MD PhD",
        "Fausto Castagnetti, MD",
        "Francesca Lunghi, MD",
        "Serena Rupoli, MD",
        "Elisabetta Abruzzese, MD",
        "Massimo Breccia, MD PhD",
        "Alessandra Iurlo, MD PhD",
        "Bruno Martino",
        "Patrizia Pregno, MD",
        "Mario Tiribelli, MD",
        "Giovanna Rege Cambrin",
        "Giuseppe Tagariello",
        "Laura Nocilli",
        "Antonietta Pia Falcone, MD",
        "Debora Luzi",
        "Monica Crugnola, MD",
        "Sara Barulli, MD",
        "Massimiliano Bonifacio, MD",
        "Sabina Russo",
        "Delia Noli, MD",
        "Simona Soverini, PhD",
        "Robin Fo\u00e0, MD",
        "Michele Cavo, MD",
        "Giovanni Martinelli, MD",
        "Fabrizio Pane, MD",
        "Giuseppe Saglio, MD PhD",
        "Michele Baccarani, MD",
        "Gianantonio Rosti, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Gabriele Gugliotta, MD PhD",
            "author_affiliations": [
                "Department of Experimental Diagnostic and Specialty Medicine - DIMES Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Fausto Castagnetti, MD",
            "author_affiliations": [
                "Hematology/Oncology \"Seragnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Lunghi, MD",
            "author_affiliations": [
                "U.O. Ematologia e Trapianto di Midollo Osseo, Ospedale San Raffaele IRCCS, Milan, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Serena Rupoli, MD",
            "author_affiliations": [
                "Hematology Unit, AOU- Ospedali Riuniti Umberto I, Ancona, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisabetta Abruzzese, MD",
            "author_affiliations": [
                "Hematology Unit, S.Eugenio Hospital, Tor Vergata University, Rome, ITA "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Breccia, MD PhD",
            "author_affiliations": [
                "Dipartimento Biotecnologie Cellulari, University of Rome \"Sapienza\", Roma, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Iurlo, MD PhD",
            "author_affiliations": [
                "Hematology Division, IRCCS C\u00e0 Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bruno Martino",
            "author_affiliations": [
                "Azienda Ospedaliera \"Bianchi Melacrino Morelli\", Reggio Calabria, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrizia Pregno, MD",
            "author_affiliations": [
                "AZ OSP CITTA' DELLA SALUTE E SCIENZA TORINO, University of Torino, TORINO, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mario Tiribelli, MD",
            "author_affiliations": [
                "Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giovanna Rege Cambrin",
            "author_affiliations": [
                "University of Turin, ORBASSANO TORINO, ITA "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Tagariello",
            "author_affiliations": [
                "Regional General Hospital, Castelfranco Veneto, ITA "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Laura Nocilli",
            "author_affiliations": [
                "Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte, Messina, ITA "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonietta Pia Falcone, MD",
            "author_affiliations": [
                "IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Debora Luzi",
            "author_affiliations": [
                "Azienda Ospedaliera - S. Maria Di Terni, Bologna, ITA "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Crugnola, MD",
            "author_affiliations": [
                "Division of Hematology, University Hospital of Parma, Parma, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sara Barulli, MD",
            "author_affiliations": [
                "Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore, Pesaro, Italy "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimiliano Bonifacio, MD",
            "author_affiliations": [
                "Department of Medicine, Section of Haematology, University of Verona, Verona, Italy "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sabina Russo",
            "author_affiliations": [
                "Dipartimento di Medicina Interna, AOU Policlinico di Messina, Messina, Italy "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Delia Noli, MD",
            "author_affiliations": [
                "San Francesco Hospital, Nuoro, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Simona Soverini, PhD",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Castel Maggiore, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Robin Fo\u00e0, MD",
            "author_affiliations": [
                "Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Policlinico Umberto I, Rome, Italy "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Cavo, MD",
            "author_affiliations": [
                "Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. e A. Seragnoli, University of Bologna, Bologna, Italy "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giovanni Martinelli, MD",
            "author_affiliations": [
                "Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \"L. and A. Seragnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrizio Pane, MD",
            "author_affiliations": [
                "Hematology - Departments of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Saglio, MD PhD",
            "author_affiliations": [
                "University of Turin, Dept. of Clinical and Biological Sciences, Orbassano, Italy "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Baccarani, MD",
            "author_affiliations": [
                "Institute of Hematology \"L. e A. Ser\u00e0gnoli\", University of Bologna, Bologna, Italy "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gianantonio Rosti, MD",
            "author_affiliations": [
                "Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology \"L. and A. Ser\u00e0gnoli\", S.Orsola-Malpighi University Hospital, Bologna, Italy ",
                "Institute of Hematology \" L. & A. Ser\u00e0gnoli\",, St. Orsola University Hospital, Bologna, Italy"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-11T12:46:37",
    "is_scraped": "1"
}